Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (75.0%)
N/A1 (25.0%)

Trials by Status

completed125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma

NCT04340440
unknownphase_3

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

NCT03264807
unknownphase_3

Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2

NCT02356276
unknownphase_3

Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer

NCT02240524

Clinical Trials (4)

Showing 4 of 4 trials
NCT04340440Not Applicable

Curative D2 vs D1 Lymphadenectomy in Operable Gastric Carcinoma

Completed
NCT03264807Phase 3

Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer

Unknown
NCT02356276Phase 3

Efficacy of HIPEC in the Treatment of Locally Advanced Gastric Cancer After radIcal Gastrectomy With D2

Unknown
NCT02240524Phase 3

Efficacy of HIPEC in the Treatment of Patients With Locally Advanced Gastric Cancer

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4